Larry Douglas Altstiel - Net Worth and Insider Trading

Larry Douglas Altstiel Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Larry Douglas Altstiel owns 3 companies in total, including vTv Therapeutics Inc (VTVT) , Neurotrope Inc (NTRP) , and ProMIS Neurosciences Inc (PMN) .

Click here to see the complete history of Larry Douglas Altstiel’s form 4 insider trades.

Insider Ownership Summary of Larry Douglas Altstiel

Ticker	Comapny	Transaction Date	Type of Owner
VTVT	vTv Therapeutics Inc	2015-12-01	Chief Medical Officer
NTRP	Neurotrope Inc	2015-11-19	director
PMN	ProMIS Neurosciences Inc	2023-10-26	Chief Medical Officer

Larry Douglas Altstiel Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Larry Douglas Altstiel Ownership Network

Ownership Network List of Larry Douglas Altstiel

No Data

Ownership Network Relation of Larry Douglas Altstiel

Larry Douglas Altstiel Owned Company Details

What does vTv Therapeutics Inc do?

Who are the key executives at vTv Therapeutics Inc?

Larry Douglas Altstiel is the Chief Medical Officer of vTv Therapeutics Inc. Other key executives at vTv Therapeutics Inc include Chief Financial Officer Steven L. Tuch , director & President and CEO Paul J Sekhri , and director & 10 percent owner G42 Investments Ai Holdings Rsc Ltd. .

vTv Therapeutics Inc (VTVT) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of vTv Therapeutics Inc (VTVT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of vTv Therapeutics Inc (VTVT) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

vTv Therapeutics Inc (VTVT)'s detailed insider trading history can be found in Insider Trading Tracker table.

vTv Therapeutics Inc Insider Transactions

No Available Data

What does Neurotrope Inc do?

Who are the key executives at Neurotrope Inc?

Larry Douglas Altstiel is the director of Neurotrope Inc. Other key executives at Neurotrope Inc include director & Chief Executive Officer Charles S. Ryan , COO and General Counsel Michael Ciraolo , and See Remarks Robert Weinstein .

Neurotrope Inc (NTRP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Neurotrope Inc (NTRP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Neurotrope Inc (NTRP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Neurotrope Inc (NTRP)'s detailed insider trading history can be found in Insider Trading Tracker table.

Neurotrope Inc Insider Transactions

No Available Data

What does ProMIS Neurosciences Inc do?

Who are the key executives at ProMIS Neurosciences Inc?

Larry Douglas Altstiel is the Chief Medical Officer of ProMIS Neurosciences Inc. Other key executives at ProMIS Neurosciences Inc include Chief Financial Officer Daniel E. Geffken , 10 percent owner Jeremy M. Sclar , and director & Chief Executive Officer Gail M Farfel .

ProMIS Neurosciences Inc (PMN) Insider Trades Summary

Over the past 18 months, Larry Douglas Altstiel made no insider transaction in ProMIS Neurosciences Inc (PMN). Other recent insider transactions involving ProMIS Neurosciences Inc (PMN) include a net purchase of 93,223 shares made by Michael S Gordon , and a net purchase of 10,000 shares made by Patrick D. Kirwin .

In summary, during the past 3 months, insiders sold 0 shares of ProMIS Neurosciences Inc (PMN) in total and bought 103,223 shares, with a net purchase of 103,223 shares. During the past 18 months, 0 shares of ProMIS Neurosciences Inc (PMN) were sold and 103,223 shares were bought by its insiders, resulting in a net purchase of 103,223 shares.

ProMIS Neurosciences Inc (PMN)'s detailed insider trading history can be found in Insider Trading Tracker table.

ProMIS Neurosciences Inc Insider Transactions

No Available Data

Larry Douglas Altstiel Mailing Address

Above is the net worth, insider trading, and ownership report for Larry Douglas Altstiel. You might contact Larry Douglas Altstiel via mailing address: C/o Neurotrope, Inc., 50 Park Place, Suite 1401, Newark Nj 07102.

Discussions on Larry Douglas Altstiel

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.